All News ProMIS Neurosciences, Inc.

Equities

PMN

CA74346M4065

Market Closed - Nasdaq Other stock markets 02:00:00 18/05/2024 am IST			5-day change	1st Jan Change
1.845 ^USD	-7.75%		-2.38%	+60.43%

15/05	ProMIS Neurosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
30/04	ProMIS Neurosciences, Inc. Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed Antibodies	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ProMIS Neurosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05	CI
ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights	15/05	AQ
ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed Antibodies	30/04	AQ
ProMIS Neurosciences, Inc. Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed Antibodies	30/04	CI
ProMIS Neurosciences Publishes in the Journal of Biological Chemistry on the Interaction Between Pathogenic Proteins as a Treatment Target for ALS	09/04	AQ
ProMIS Neurosciences Inc. Publishes in the Journal of Biological Chemistry on the Interaction Between Pathogenic Proteins as A Treatment Target for ALS	09/04	CI
ProMIS Neurosciences to Present in Upcoming Investor Conferences in April	05/04	AQ
ProMIS Neurosciences to Present in Upcoming Investor Conferences in April	04/04	AQ
ProMIS Neurosciences Announces Full Year 2023 Financial Results and Recent Highlights	02/04	AQ
ProMIS Neurosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02/04	CI
ProMIS Neurosciences : Corporate Overview	29/03	PU
ProMIS Neurosciences Strengthens Global Intellectual Property Portfolio	11/03	AQ
ProMIS Neurosciences to Present at the 2024 BIO CEO & Investor Conference	22/02	AQ
ProMIS Neurosciences Achieves Milestone in Development of Therapeutic Alpha-Synuclein Vaccine	22/01	AQ
ProMIS Neurosciences Issues Letter to Shareholders	08/01	AQ
ProMIS Neurosciences, Inc. Announces Management Changes	03/01	CI
ProMIS Neurosciences, Inc. Announces CEO Changes	03/01	CI
ProMIS Neurosciences, Inc. Announces Leadership Transition	03/01	AQ
ProMIS Neurosciences Announces Publication on Novel Target for ALS	20/12	AQ
ProMIS Neurosciences Announces Publication on Novel Target for ALS	20/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News ProMIS Neurosciences, Inc.

Equities

PMN

CA74346M4065

All News

Filters